Molecular markers of endometrial carcinoma detected in uterine aspirates-Reference-Cited by-同舟云学术

Molecular markers of endometrial carcinoma detected in uterine aspirates

Published:2011-04-08 Issue:10 Volume:129 Page:2435-2444
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Colas Eva,Perez Cristina,Cabrera Silvia,Pedrola Nuria,Monge Marta,Castellvi Josep,Eyzaguirre Fernando,Gregorio Jesus,Ruiz Anna,Llaurado Marta,Rigau Marina,Garcia Marta,Ertekin Tugçe,Montes Melania,Lopez-Lopez Rafael,Carreras Ramon,Xercavins Jordi,Ortega Alicia,Maes Tamara,Rosell Elisabet,Doll Andreas,Abal Miguel,Reventos Jaume,Gil-Moreno Antonio

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference16 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up;Baekelandt;Ann Oncol,2009

3. Molecular determinants of invasion in endometrial cancer;Abal;Clin Transl Oncol,2007

4. A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes;Baldi;Bioinformatics,2001

5. Subtractive proteomic approach to the endometrial carcinoma invasion front;Monge;J Proteome Res,2009

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acetyl-CoA acyltransferase 1 is a potential tumor suppressor gene associated with immune cell infiltration in nasopharyngeal carcinoma;2024-08-26

2. Endoplasmic reticulum stress promotes hepatocellular carcinoma by modulating immunity: a study based on artificial neural networks and single-cell sequencing;Journal of Translational Medicine;2024-07-15

3. FASTKD1 as a diagnostic and prognostic biomarker for STAD: Insights into m6A modification and immune infiltration;Experimental and Therapeutic Medicine;2024-05-31

4. Multi-ancestry meta-analysis of host genetic susceptibility to tuberculosis identifies shared genetic architecture;eLife;2024-01-15

5. Three novel rare TP53 fusion mutations in a patient with multiple primary cancers: a case report;Oncology and Translational Medicine;2024-01-07